DAG is linked to altered insulin signaling and insulin resistance through the activation of hepatic protein kinase C [77], which results in reduced insulin-stimulated phosphorylation of IRS-2 and Akt2 and, thereby, the ability to activate glycogen synthesis and decrease gluconeogenesis [78]. The gene discussed is INS; the disease is Insulin resistance.